Status:
COMPLETED
Clinical Outcomes of Patients with a Light Adjustable Lens (LAL) in At Least One Eye
Lead Sponsor:
Bucci Laser Vision Institute
Conditions:
IOL
Eligibility:
All Genders
18+ years
Brief Summary
To collect data on bilateral pseudophakic patients implanted with the RxSight Light Adjustable Lens (LAL) in at least one eye
Eligibility Criteria
Inclusion
- Adults with bilateral pseudophakia who have been implanted with the LAL in at least one eye and who have completed LDD light treatments
Exclusion
- Visually significant eye disease
Key Trial Info
Start Date :
August 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06016231
Start Date
August 15 2023
End Date
December 31 2023
Last Update
October 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bucci Laser Vision Institute
Wilkes-Barre, Pennsylvania, United States, 18702